| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 699671 | Null | 0.0438391811600412 | 0.25072031 |
| NSC 701100 | 2H-1-Benzopyran-2-one, 6-chloro-3-[imidazo[1,2-a]pyridin-2-yl]- | 0.0438391811600412 | -0.19596901 |
| NSC 708073 | Null | 0.0438391811600412 | 0.12570861 |
| NSC 740275 | 5,6-Dihydro-6-(3-morpholinyl-1-propyl)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0438391811600418 | -0.17760335 |
| NSC 741738 | 1-(7-Methoxy-3-methyl-1,4-dioxy-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone | 0.0438391811600418 | -0.1161116 |
| NSC 81052 | Streptonigrin analog (MeO-N3) | 0.0438391811600418 | 0.39093589 |
| NSC 102225 | Null | 0.0478540623811426 | 0.22558607 |
| NSC 107043 | Null | 0.0478540623811426 | 0.079779989 |
| NSC 132275 | Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) | 0.0478540623811426 | 0.10794183 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0478540623811426 | -0.085360674 |